biomea fusion
Gregory Birgfeld has extensive experience in the field of digital and social media communications in the biotech and biopharma sectors. Gregory has held various leadership roles in companies such as Biomea Fusion, Eikon Therapeutics, and Sangamo Therapeutics, where they were involved in redesigning and launching branding, corporate websites, and intranet sites. Gregory also created social media strategies and listening platforms to enhance corporate visibility. Prior to these roles, Birgfeld worked as an Executive Director of Digital/Social Communications & Marketing Strategy and a Vice President at Edelman, where they developed global digital and communications strategies for healthcare clients. Gregory has also served as a Senior Director of Corporate & Brand Communications at Berkeley Lights, Inc. and a Senior Director of Digital and Social Media at Pharmacyclics, LLC. Earlier in their career, they worked in social media and creative roles at Onyx Pharmaceuticals/Amgen and Cepheid. Birgfeld started their career as a Senior Production Designer at Haggin Marketing. Overall, they have demonstrated expertise and a comprehensive understanding of digital and social media communications in the biotech and biopharma industries.
Gregory Birgfeld attended the University of Maine starting in 1988 and studied Design and Visual Communications, General.
This person is not in any offices
biomea fusion
Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.